This site is intended for healthcare professionals
Last reviewed dd mmm yyyy. Last edited dd mmm yyyy
Zanamivir is a specific inhibitor of influenza virus neuraminidase. Zanamivir is licensed for the treatment of influenza A and B.
In clinical trials Zanamivir:
Note that when influenza is active in a community 60-80% of patients with flu-like symptoms will have influenza. If there is not a influenza outbreak the accuracy of clinical
The summary of product characteristics should be consulted before prescribing this drug.
Zanamivir may be prescribed to at risk individuals when influenza is circulating in the community.